Observational studyWorld journal of urology2015

Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.

Thomas Höfner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.